Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due......(read more)
Posts Tagged ‘NASDAQ:ACAD’
Were Hedge Funds Right About Flocking Into ACADIA Pharmaceuticals Inc. (ACAD)?
Is ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours......(read more)
Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy?
“Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting......(read more)
Hedge Fund and Insider Trading News: Crispin Odey, Third Point LLC, Criterion Capital, Twitter Inc (TWTR), ACADIA Pharmaceuticals Inc. (ACAD), and More
Crispin Odey’s Comeback Gets a Boost After Hedge Fund Surges (Bloomberg) Crispin Odey, whose bearish bets led to his hedge fund suffering three successive......(read more)
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (NASDAQ:ACAD)
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the......(read more)
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......(read more)
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Manager’s Top Stock Picks for 2017
Mott Capital Management is a long-only fund managed by Michael Kramer. The fund usually invests in stocks with a horizon of 3-5 years and seeks to provide......(read more)
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what......(read more)
Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects
March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks. The fund was started in......(read more)
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......(read more)
Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced......(read more)
Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today
U.S. stock indexes are up substantially in Friday trading, with the S&P 500 hitting record highs, driven by a surprisingly strong jobs report out......(read more)
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......(read more)
Why These Five Stocks Are Gaining Ground Today
The US stocks rallied on Wednesday after the dovish comments from Federal Reserve Chairwoman Janet Yellen on Tuesday. Among the prominent stocks that......(read more)
Why Are These Five Stocks In Spotlight Today?
U.S. equities inched up on Monday after fresh data displayed that consumer spending rose marginally in February. The Commerce Department revealed that......(read more)
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
ACADIA Pharmaceuticals Inc. (ACAD): Are Hedge Funds Right About This Stock?
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge......(read more)
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore......(read more)
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector
Hal Mintz‘s Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action......(read more)
Newfield Exploration Co. (NFX), ACADIA Pharmaceuticals Inc. (ACAD): How Did Andreas Halvorsen’s Small-Cap Picks Perform in Q3?
Andreas Halvorsen‘s Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking’s flagship fund......(read more)
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’......(read more)
Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and......(read more)
Hedge Fund News: Bill Miller, Richard Perry & Alphonse Fletcher
Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary......(read more)
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to......(read more)
Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech
Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech......(read more)
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to......(read more)
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated......(read more)
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......(read more)
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most......(read more)
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Rite Aid Corporation (RAD), Questcor Pharmaceuticals Inc (QCOR): Are Any Of These Top Performers A Sell?
I began using Motley Fool’s CAPS as a way to disclose when I purchased and sold stocks, and my 97.2 rating showcases my last 10 months. CAPS compares......(read more)
Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year
Buyout! The word gets biotech investors’ blood flowing and their hearts racing. Mere rumors that a biotech stock could get bought out can send shares......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year. This growth is due......(read more)
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Rite Aid Corporation (RAD) & More: Are These Top Performers Still a “Buy”?
I am looking at the top performers from my portfolio over the last year, and deciding whether or not it is time to take profits; many of these stocks......(read more)
ACADIA Pharmaceuticals Inc. (ACAD): Look Before You Leap With This Company
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a bio-pharmaceutical company that specializes in the innovation of small-molecule drugs that are used to......(read more)
Celldex Therapeutics, Inc. (CLDX), ACADIA Pharmaceuticals Inc. (ACAD): Two Biotech Stocks That Could Soon be Acquired
While a company is in the clinical phase of development, there are roughly four catalysts that could move the stock higher. 1. Expansion of intellectual......(read more)
Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has seen a decrease in hedge fund interest of late. According to most shareholders, hedge funds are seen as......(read more)
Hedge Funds Are Dumping Optimer Pharmaceuticals, Inc. (OPTR)
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds’ portfolio at the end of March. OPTR investors should be aware of a decrease in......(read more)
ACADIA Pharmaceuticals Inc. (ACAD): What’s Next For This Biotech?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’ 1,100% gain makes it one of the best performing stocks in the market. This rally began after its Parkinson......(read more)
Hedge Funds Are Buying EXACT Sciences Corporation (EXAS)
EXACT Sciences Corporation (NASDAQ:EXAS) investors should be aware of an increase in hedge fund sentiment lately. At the moment, there are tons of metrics......(read more)
ACADIA Pharmaceuticals Inc. (ACAD) Soars On Hedge Fund Investment
One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are......(read more)
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Three Humongous Health-Care Stocks This Week
Summer doesn’t officially arrive for a few more weeks, but the first week of June packed some real heat. That’s especially true for three......(read more)
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) investors should be aware of a decrease in enthusiasm from smart money lately. To most market participants,......(read more)
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
Halozyme Therapeutics, Inc. (NASDAQ:HALO) has seen an increase in activity from the world’s largest hedge funds lately. To the average investor,......(read more)
A Trio Of ACADIA Pharmaceuticals Inc. (ACAD) Indicators To Watch
Nowadays, there are many facts and figures for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) investors to track, but it is smart to take note of a company......(read more)
Three Keys to ACADIA Pharmaceuticals Inc. (ACAD)’s Future
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had a busy couple of months. The new member of the Nasdaq Biotechnology Index recently completed a $150 million......(read more)
